Patiromer bulk supplier for pharma manufacturers

Patiromer 8.4 mg Suppliers & Bulk Manufacturers

Available Forms: Sachet

Available Strengths: 8.4 mg

Reference Brands: Veltassa®(US) Generics

Patiromer 8.4 g Sachet is used to treat hyperkalemia in patients with chronic kidney disease (CKD) or those on RAAS inhibitors. It helps lower elevated potassium levels by binding to potassium in the gastrointestinal tract, reducing the risk of cardiovascular complications.

Get Enquiry / Request Bulk Quote

Usually answered within 48 hours | GMP documents shared before you commit

Manufacture or export Patiromer? List it or send an offer →

Product Description:

Patiromer 8.4 g Sachet is a key treatment in nephrology for managing hyperkalemia in patients with chronic kidney disease (CKD) or those on RAAS inhibitors. This potassium-binding medication helps lower elevated potassium levels in the blood, reducing the risk of cardiovascular complications. Available in a convenient 8.4 g sachet form, Patiromer is widely used in hospital and clinical settings across the US and EU. For pharma B2B in these regions, it provides a reliable solution for healthcare providers managing electrolyte imbalances in high-risk patients. Patiromer’s efficacy and safety make it an essential product in nephrology care.

Patiromer — third party manufacturing & bulk supply

Patiromer 8.4 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Patiromer is supplied as Sachet — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Patiromer listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Patiromer →

Usually answered within 48 hours, with matched manufacturers, indicative prices and document status.

Back to Listing

Frequently Asked Questions

Patiromer is listed as Sachet in 8.4 mg. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Patiromer is referenced against Veltassa®(US) Generics. Reference brands are shown for identification only and remain the property of their respective trademark owners.